PHASE II TRIAL OF A SURVIVIN VACCINE (SurVaxM) FOR NEWLY DIAGNOSED GLIOBLASTOMA

被引：0

作者：

Ahluwalia, Manmeet ^{[1
]}

Reardon, David ^{[2
]}

Abad, Ajay ^{[3
]}

Curry, William ^{[4
]}

Wong, Eric ^{[5
]}

Peereboom, David ^{[1
]}

Belal, Ahmed ^{[3
]}

Qiu, Jingxin ^{[3
]}

Mogensen, Kathleen ^{[3
]}

Schilero, Cathy ^{[1
]}

Casucci, Danielle ^{[3
]}

Mechtler, Laszlo ^{[3
]}

Uhlmann, Erik ^{[3
]}

Ciesielski, Michael ^{[3
]}

Fenstermaker, Robert ^{[3
]}

机构：

[1] Cleveland Clin, Cleveland, OH 44106 USA

[2] Dana Farber Canc Inst, Boston, MA 02115 USA

[3] Roswell Pk Canc Inst, Buffalo, NY 14263 USA

[4] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02115 USA

[5] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

来源：

NEURO-ONCOLOGY | 2018年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ATIM-41

引用

页码：10 / 11

页数：2

共 50 条

[1] PHASE II TRIAL OF SURVAXM PLUS TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA
Ahluwalia, Manmeet
Ciesielski, Michael J.
Reardon, David A.
Abad, Ajay
Curry, William
Wong, Eric
Peereboom, David
Figel, Sheila
Hutson, Alan
Groman, Adrienne
Withers, Henry
Liu, Song
Belal, Ahmed
Qiu, Jingxin
Mogensen, Kathleen
Schilero, Cathy
Khosla, Atulya
Casucci, Danielle
Mechtler, Laszlo
Fenstermaker, Robert
NEURO-ONCOLOGY, 2022, 24 : 66 - 66
[2] SurVaxM with standard therapy in newly diagnosed glioblastoma: Phase II trial update.
Ahluwalia, Manmeet Singh
Reardon, David A.
Abad, Ajay P.
Curry, William T.
Wong, Eric T.
Belal, Ahmed
Qiu, Jingxin
Mogensen, Kathleen
Schilero, Cathy
Hutson, Alan
Casucci, Danielle
Mechtler, Laszlo
Uhlmann, Erik J.
Ciesielski, Michael J.
Fenstermaker, Robert
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[3] Phase II trial of SurVaxM combined with standard therapy in patients with newly diagnosed glioblastoma.
Ahluwalia, Manmeet Singh
Reardon, David A.
Abad, Ajay P.
Curry, William T.
Wong, Eric T.
Belal, Ahmed
Qiu, Jingxin
Mogensen, Kathleen
Schilero, Cathy
Casucci, Danielle
Mechtler, Laszlo
Uhlmann, Erik J.
Ciesielski, Michael J.
Fenstermaker, Robert
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[4] A multicenter, randomized controlled phase 2b trial of survivin vaccine SurVaxM plus adjuvant temozolomide for newly diagnosed glioblastoma (SURVIVE).
Ahluwalia, Manmeet Singh
Ciesielski, Michael J.
Reardon, David A.
Butowski, Nicholas A.
Aiken, Robert
Venur, Vyshak
Abad, Ajay Prakash
Mechtler, Laszlo
Peereboom, David M.
Odia, Yazmin
Sinicrope, Kaylyn
Boockvar, John A.
Brenner, Andrew J.
Barbaro, Marissa
Ozair, Ahmad
Belal, Ahmed
Qiu, Jing-Xin
Khosla, Atulya Aman
Casucci, Danielle M.
Fenstermaker, Robert Alan
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[5] A MULTICENTER, RANDOMIZED, CONTROLLED PHASE 2B TRIAL OF SURVIVIN VACCINE SURVAXM PLUS ADJUVANT TEMOZOLOMIDE FOR NEWLY-DIAGNOSED GLIOBLASTOMA (SURVIVE)
Ahluwalia, Manmeet
Ciesielski, Michael
Abad, Ajay
Reardon, David
Ozair, Ahmad
Khosla, Atulya
Aiken, Robert
Barbaro, Marissa
Sinicrope, Kaylyn
Peereboom, David
Odia, Yazmin
Brenner, Andrew
Venur, Vyshak
Belal, Ahmed
Qiu, Jingxin
Schilero, Cathy
Casucci, Danielle
Mechtler, Laszlo
Fenstermaker, Robert
NEURO-ONCOLOGY, 2024, 26
[6] A RANDOMIZED PHASE 2B STUDY OF SURVIVIN VACCINE SURVAXM PLUS ADJUVANT TEMOZOLOMIDE FOR NEWLY-DIAGNOSED GLIOBLASTOMA (SURVIVE)
Ahluwalia, M. S.
Ciesielski, M.
Abad, A.
Reardon, D.
Aiken, R.
Barbaro, M.
Sinicrope, K.
Peereboom, D. M.
Odia, Y.
Brenner, A.
Venur, V.
Butowski, N.
Belal, A.
Qiu, J.
Ozair, A.
Khosla, A. A.
Schilero, C.
Figel, S.
Casucci, D.
Mechtler, L.
Fenstermaker, R.
NEURO-ONCOLOGY, 2023, 25
[7] PROSPECTIVE RANDOMIZED PHASE II PLACEBO-CONTROLLED TRIAL OF SURVAXM PLUS ADJUVANT TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA (SURVIVE)
Ahluwalia, Manmeet
Ciesielski, Michael J.
Abad, Ajay
Reardon, David A.
Aiken, Robert
Barbaro, Marissa
Sinicrope, Kaylyn
Peereboom, David
Odia, Yazmin
Brenner, Andrew
Venur, Vyshak
Belal, Ahmed
Qiu, Jingxin
Khosla, Atulya
Schilero, Cathy
Casucci, Danielle
Mechtler, Laszlo
Fenstermaker, Robert
NEURO-ONCOLOGY, 2022, 24 : 64 - 64
[8] Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma
Ahluwalia, Manmeet S.
Reardon, David A.
Abad, Ajay P.
Curry, William T.
Wong, Eric T.
Figel, Sheila A.
Mechtler, Laszlo L.
Peereboom, David M.
Hutson, Alan D.
Withers, Henry G.
Liu, Song
Belal, Ahmed N.
Qiu, Jingxin
Mogensen, Kathleen M.
Dharma, Sanam S.
Dhawan, Andrew
Birkemeier, Meaghan T.
Casucci, Danielle M.
Ciesielski, Michael J.
Fenstermaker, Robert A.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (07) : 1453 - +
[9] Final data from the phase 2a single-arm trial of SurVaxM for newly diagnosed glioblastoma
Ciesielski, Michael J.
Ahluwalia, Manmeet Singh
Reardon, David A.
Abad, Ajay P.
Curry, William T.
Wong, Eric T.
Peereboom, David M.
Figel, Sheila A.
Hutson, Alan
Groman, Adrienne
Withers, Henry G.
Liu, Song
Belal, Ahmed
Qiu, Jing-Xin
Mogensen, Kathleen
Schilero, Cathy
Casucci, Danielle M.
Mechtler, Laszlo
Fenstermaker, Robert Alan
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[10] Results of a Phase Ib trial of an autologous cell vaccine for newly diagnosed glioblastoma
Andrews, David W.
Garcia, Samantha
Judy, Kevin D.
Harshyne, Larry A.
Govindarajan, Sanjana
Kenyon, Lawrence
Talekar, Kiran
Flanders, Adam
Atsina, Kofi-Buaku
Kim, Lyndon
Martinez, Nina L.
Shi, Wenyin
Werner-Wasik, Maria
Prosniak, Mikhail
Curtis, Mark T.
Kean, Rhonda
Bongiorno, Emily
Sauma, Sami
Pigott, Kara
Scott, Charles B.
Hooper, D. Craig
CANCER RESEARCH, 2019, 79 (13)

← 1 2 3 4 5 →